The potential of stem cells in pain management

The potential of stem cells in pain management is now recognized worldwide, because chronic pain is one of the most widespread and debilitating clinical conditions in the world. The NefroCenter Group uses this innovative method in Pain Therapy care at its facilities. According to the World Health Organization, chronic pain affects about 20% of the adult population and is frequently associated with depression, anxiety, loss of quality of life and a significant reduction in work productivity. Conventional drug therapies – such as analgesics, nonsteroidal anti-inflammatory drugs (NSAIDs) and opioids – often do not provide lasting relief and can come with side effects, sometimes serious ones. Stem cells represent a promising therapeutic alternative, thanks to their ability to regenerate tissues, modulate inflammation and promote repair processes in damaged tissues.

What stem cells are

Stem cells are “unspecialized” cells able to replicate themselves (self-renew) and to differentiate into different cell types (osteoblasts, chondrocytes, neurons, etc.). There are several types of stem cells, but in clinical practice, for pain management, the ones used most are:

• Mesenchymal stem cells (MSCs): isolated from bone marrow, adipose tissue, umbilical cord or dental pulp. MSCs, in particular, are among the most studied for clinical use thanks to their plasticity, easy accessibility and immunomodulatory capacity.
• Hematopoietic stem cells: involved in the regeneration of the blood and of the immune system.
• Neural stem cells: still the subject of research, with particular interest in the treatment of neuropathic pain.

How stem cells act in Pain Therapy

The action of stem cells is not exclusively regenerative. In recent years it has become clear that they exert a powerful paracrine action, that is, they release a series of bioactive molecules (cytokines, growth factors, microvesicles) capable of:

• Reducing chronic inflammation
• Inhibiting sensitization of the peripheral and central nervous system
• Promoting the repair of damaged tissues (cartilage, muscle, bone, nerves)
• Reducing fibrosis

These mechanisms of action are particularly useful in various chronic painful conditions, such as osteoarthritis, chronic low back pain, neuropathic pain (from diabetes, herpes zoster, multiple sclerosis), post-traumatic or post-surgical musculoskeletal pain and fibromyalgia (in the experimental phase).

Clinical applications

1. Osteoarthritis

One of the most promising areas is the use of mesenchymal stem cells in osteoarthritis, especially of the knee. Several randomized clinical studies have shown that intra-articular injection of autologous MSCs (that is, derived from the patient’s own body, usually from bone marrow or adipose tissue) significantly reduces pain and improves joint function. A study published as early as 2019 compared the results of patients with knee osteoarthritis treated with MSCs against a group treated with hyaluronic acid: the stem cell group showed a longer-lasting improvement in pain and a partial regeneration of cartilage visible on magnetic resonance imaging.

2. Chronic low back pain

Another interesting application concerns low back pain caused by degeneration of the intervertebral disc. Here, MSCs can be injected directly into the damaged disc, where they help reduce local inflammation and slow the degenerative process. A 2017 study showed that patients with chronic low back pain refractory to conventional treatments, treated with MSCs from bone marrow, reported a significant reduction in pain as early as 3 months later, which was maintained up to 12 months.

3. Neuropathic pain

Neuropathic pain is caused by damage to the nervous system and is often resistant to traditional drugs. In animal models, MSCs have been shown to modulate the neuroinflammatory response, restoring the balance between pro-inflammatory and anti-inflammatory cytokines. In trials on small groups of patients with diabetic neuropathy or brachial plexus injuries, local or systemic injections of MSCs showed a significant reduction in pain and an improvement in sensation.

Advantages of the stem cell approach

The main advantages of the stem cell approach are its regenerative, not merely symptomatic, nature. They also include its multi-target action: anti-inflammatory, restorative and neuroprotective. It carries a reduced risk of rejection (especially with autologous cells) and minimal documented side effects in current applications.

The future of regenerative medicine in pain

Interest in the use of stem cells in pain management is constantly growing. Researchers are exploring new cell sources (such as cells from the placenta or the amniotic fluid), new routes of administration (intravenous, intrathecal) and combination with biomaterials and three-dimensional scaffolds to improve the survival and effectiveness of the transplanted cells. At the same time, the concept of “personalized medicine” is gaining ground, in which the patient’s genetic characteristics and the local microenvironment guide the choice of cell type, dose and treatment protocol. Stem cells therefore represent a new and promising frontier in the management of chronic pain.